AVALO THERAPEUTICS, INC. Temporary Equity, Carrying Amount, Attributable to Parent
AVALO THERAPEUTICS, INC. (AVTX) had Temporary Equity, Carrying Amount, Attributable to Parent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Temporary Equity
us-gaap:TemporaryEquityCarryingAmountAttributableToParent · last filed 2026-08-06
- 2026-06-30: Temporary Equity, Carrying Amount, Attributable to Parent $0.00.
- 2026-03-31: Temporary Equity, Carrying Amount, Attributable to Parent $0.00.
- 2025-12-31: Temporary Equity, Carrying Amount, Attributable to Parent $0.00.
- 2025-09-30: Temporary Equity, Carrying Amount, Attributable to Parent $0.00.
| Period end | Temporary Equity, Carrying Amount, Attributable to Parent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-06 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-Q · filed 2026-08-06 |
| 2024-09-30 | $1.66M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $11.46M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $11.46M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $0.00 10-K · filed 2026-03-23 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2015-09-30 | $28.35M 10-Q · filed 2015-11-13 |
| 2014-12-31 | $28.35M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |